Finance

Lists
300791:SHE
Sirio Pharma Co Ltd
CNÂ¥16.62
+0.36%
(+0.060) 1D
Oct 30, 3:04:07 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300791...
Open
CNÂ¥16.56
High
CNÂ¥17.02
Low
CNÂ¥16.32
Mkt. cap
5.12B
Avg. vol.
1.71M
Volume
1.19M
Dividend
0.78%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 5, 2026
P/E ratio
45.29
52-wk high
CNÂ¥26.17
52-wk low
CNÂ¥15.40
EPS
CNÂ¥0.37
Shares outstanding
308.23M
No. of employees
3K
Open
CNÂ¥16.56
High
CNÂ¥17.02
Low
CNÂ¥16.32
Mkt. cap
5.12B
Avg. vol.
1.71M
Volume
1.19M
Dividend
0.78%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 5, 2026
P/E ratio
45.29
52-wk high
CNÂ¥26.17
52-wk low
CNÂ¥15.40
EPS
CNÂ¥0.37
Shares outstanding
308.23M
No. of employees
3K
News stories
From web sources and news partners
About Sirio Pharma Co Ltd
CEO-
Employees2.78K
FoundedAug 16, 1993
Headquarters-
SectorPersonal care products
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
971.73M
1.00B
1.05B
1.01B
Cost of goods sold
813.57M
678.46M
671.75M
666.45M
Cost of revenue
813.57M
678.46M
671.75M
666.45M
Research and development expenses
45.42M
30.12M
34.04M
30.95M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
212.36M
194.40M
200.73M
189.97M
Operating expense
268.79M
231.64M
249.70M
226.24M
Total operating expenses
1.08B
910.10M
921.45M
892.68M
Operating income
-110.63M
93.23M
127.36M
120.21M
Other non operating income
3.74M
-19.46M
18.64M
-37.09M
EBT including unusual items
-260.84M
51.78M
114.28M
81.83M
EBT excluding unusual items
-137.27M
56.01M
91.01M
93.19M
Income tax expense
-59.41M
9.86M
13.79M
22.11M
Effective tax rate
22.78%
19.03%
12.07%
27.02%
Other operating expenses
9.89M
3.95M
8.62M
4.09M
Net income
-123.74M
49.91M
103.02M
76.94M
Net profit margin
-12.73%
4.97%
9.82%
7.60%
Earnings per share
-
-
-
-
Interest and investment income
3.03M
1.40M
2.80M
4.78M
Interest expense
-27.07M
-19.16M
-33.79M
-18.71M
Net interest expenses
-24.04M
-17.76M
-30.99M
-13.93M
Depreciation and amortization charges
-
-
-
-
EBITDA
-62.67M
-
178.95M
168.17M
Gain or loss from assets sale
-2.43M
-
-16.53M
16.53M
Upcoming events
AI content may include mistakes. Learn more
Google apps